Medical/Pharmaceuticals
First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody
HANGZHOU, China and SHAOXING, China, Aug. 17, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today dosing of the first HBV patient in Phase IIa clinical trial of ASC22, which is a first-in-class, subcutaneously administered PD-L1 antibody. ASC22(Envafolimab) Phase IIa clin...
2020-08-17 08:30
3953
China's First Trastuzumab Biosimilar Approved by NMPA
SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced onAugust 14 that the trastuzumab biosimilar HLX02, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA). On 27th July, HLX02 (EU bran...
2020-08-17 08:00
4385
Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad
HYDERABAD, India, Aug. 17, 2020 /PRNewswire/ -- Sai Life Sciences, one of
India's fastest growing Contract Development & Manufacturing Organizations
(CDMOs)
2020-08-17 08:00
3826
Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index
SUZHOU, China, and ROCKVILLE, MD., Aug. 17, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has been s...
2020-08-17 07:30
3152
Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19
SCHLIEREN, Switzerland and VILNIUS, Lithuania, Aug. 15, 2020 /PRNewswire/ -- Swiss biotech companyMemo Therapeutics AG (MTx) and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx...
2020-08-15 08:36
4657
Family Mask Supports UNGC Leaders' Summit 2020
HONG KONG, Aug. 14, 2020 /PRNewswire/ -- Family Mask is honoured to be an official supporting organization of United Nations Global Compact Leaders' Summit 2020, where more than 20,000 sustainability champions gathered over 26 hours of continuous virtual programming to address the private sector'...
2020-08-14 15:30
4222
Sinopharm Tech plans to purchase 337 tons Meltblown Fabric
HONG KONG, August 14, 2020 /PRNewswire/ -- Sinopharm Tech Holdings Limited ("Sinopharm Tech" and its subsidiaries, together, the "Group", stock code: 8156) is pleased to announce that, as of 13 August, 2020, the subsidiary of the Group has entered into product sales agreements with a branch of Pe...
2020-08-14 09:18
4906
Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters for Contempt on Patent and Trademark Infringement Case
NEW YORK, Aug. 14, 2020 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured Compensatory sanctions against counterfeiters inthe United States District Court for the Southern District of New York in a civil action against U-Bio Med, Inc., et al. The judgment orders all profits earne...
2020-08-14 02:32
4192
Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates
SHANGHAI and SAN FRANCISCO, Aug. 13, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced financial results for the six months ended June 30, 2020 and corporate updates. "This year we have continued to build Zai Lab's lead...
2020-08-13 22:38
6978
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage
SEATTLE, Aug. 13, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with Ono Pharmaceutical Co., Ltd. (ONO) to manufacture new, innovative biopharmaceuticals at the clinical development stage. ONO...
2020-08-13 21:00
4981
ANTI-PD-1/CTLA-4 Bi-specific Antibody (AK104) of Akeso Granted FDA Fast Track Designation for Recurrent and Metastatic Cervical Cancer
LOS ANGELES, Aug. 13, 2020 /PRNewswire/ -- Akeso, Inc (9926.HK) - a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide - today announced that the U.S. Food and Drug Admini...
2020-08-13 20:07
5497
Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities at its India Facility
WETTEREN, Belgium, Aug. 13, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a major expansion of small molecule manufacturing capabilities with the addition of a ...
2020-08-13 20:06
3334
CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company
SHANGHAI, Aug. 13, 2020 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SHSE: 688185, HKEX:06185) announced today that it has successfully listed on the Sci-Tech Innovation Board (STAR Market) of the Shanghai Stock Exchange, making it the first "A+ H" dual listing vaccine company. CanSinoB...
2020-08-13 10:00
10877
Australian Therapeutic Goods Administration Approves the First Phase I Trial of ATG-017 for the Treatment of Patients with Advanced Solid Tumors and Hematological Malignancies
SHANGHAI and MELBOURNE, Australia, Aug. 13, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company, announced today the authorization of the first-in-human trial of ATG-017 (ERASER trial) by the Australian Therapeutic Goods Admi...
2020-08-13 06:00
2580
Health Canada provides COVID-19 Interim Order approval for Bactiguard's endotracheal tubes
STOCKHOLM, Aug. 13, 2020 /PRNewswire/ -- Health Canada has approved Bactiguard's endotracheal tubes for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's endotracheal tubes can reduce the risk of secondary infections for critically ill patients. "...
2020-08-13 04:33
3021
Innovent and Eli Lilly Announce Acceptance of a Supplemental New Drug Application of TYVYT® (Sintilimab Injection) in Combination with Gemcitabine and Platinum as First-Line Therapy in Squamous Non-Small Cell Lung Cancer in China
SUZHOU, China, Aug. 12, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today joi...
2020-08-12 16:40
8022
PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
SHANGHAI, Aug. 11, 2020 /PRNewswire/ -- PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August toDecember 2020. Consisting of the three sessions "Top API Exporters & Products", "Popular Natura...
2020-08-11 18:35
3566
TCM Lianhua Qingwen Capsule approved for registration in the Philippines
SHIJIAZHUANG, China, Aug. 11, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd.announced on Monday that it has received a drug registration certificate issued by the Food and Drug Administration ofthe Philippines, indicating Lianhua Qingwen Capsule has been registered in accordance with the st...
2020-08-11 17:31
4243
OssDsign AB signs business partner agreement with Muranaka Medical Instruments Co., Ltd., in Japan
STOCKHOLM, Aug. 11, 2020 /PRNewswire/ -- OssDsign AB (Publ) ("OssDsign") today announced that the company has signed a business partner agreement with Muranaka Medical Instruments Co., Ltd., ("Muranaka"), a pre-eminent medical product distributor inJapan. Muranaka will represent OssDsign commerci...
2020-08-11 15:50
2681
Trendlines Medical Shanghai Opens its Doors
- Trendlines Medical Shanghai partners with Chinese medical companies,
governmental programs, and entrepreneurs to develop novel medical technologies
for the Chinese and global markets.
SHANGHAI and MISGAV, Israel, Aug. 11, 2020 /PRNewswire/ -- The Trendlines
Group Ltd.
2020-08-11 07:01
4269
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6494
